GENERIC DRUG PRODUCTS

被引:1
|
作者
ZELLMER, WA
机构
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1989年 / 46卷 / 10期
关键词
D O I
10.1093/ajhp/46.10.2005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2005 / 2005
页数:1
相关论文
共 50 条
  • [1] ACTION ON GENERIC DRUG PRODUCTS
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (14): : 1910 - 1916
  • [2] Quality assessment of generic drug products
    Rosencrance, Susan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] GENERIC DRUG SUBSTITUTION AND THE FDA LIST OF APPROVED DRUG PRODUCTS
    RUGGIERI, NL
    FOOD AND DRUG LAW JOURNAL, 1981, 36 (11): : 556 - 564
  • [4] Generic drug products in paediatrics: Where are the data?
    Illamola, Silvia M.
    Birnbaum, Angela K.
    Sherwin, Catherine M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 1871 - 1873
  • [5] Determining Equivalence for Generic Locally Acting Drug Products
    Grosser, Stella
    Park, Misook
    Raney, Sam G.
    Rantou, Elena
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (04): : 337 - 345
  • [6] BIOEQUIVALENCE OF GENERIC THIORIDAZINE DRUG PRODUCTS - THE FDA VIEWPOINT
    HAMRELL, MR
    MARTINEZ, MN
    DIGHE, SV
    PARKMAN, PD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (04): : 362 - 372
  • [7] United States food and drug administration requirements for approval of generic drug products
    Meyer, MC
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 4 - 9
  • [8] Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products
    Gagne, Joshua J.
    Sarpatwari, Ameet
    Desai, Rishi J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (02) : 313 - 315
  • [9] Generic drug device combination products: Regulatory and scientific considerations
    Choi, Stephanie H.
    Wang, Yan
    Conti, Denise S.
    Raney, Sam G.
    Delvadia, Renishkumar
    Leboeuf, Andrew A.
    Witzmann, Kimberly
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 544 (02) : 443 - 454
  • [10] Determining Equivalence for Generic Locally Acting Drug Products Comment
    Smith, Brian
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (04): : 346 - 347